Skip to main content
SpringerLink
Log in

Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection

  • Microbial Pathogenesis and Host-Microbe Interaction
  • Published:
Journal of Microbiology Aims and scope Submit manuscript

Abstract

Helicobacter pylori is among the major pathogenic bacteria that cause chronic gastritis and peptic ulcer disease and is related to the development of gastric cancer. Several chemicals, including antibiotics, have been used to eradicate H. pylori; however, they do not always curb the infection. Ten representative type strains of lactic acid bacteria (LAB) were screened for antagonism toward H. pylori via inhibition of urease activity. Strains inhibiting the binding of H. pylori to human gastric cell line cells and suppressing H. pylori-induced interleukin-8 (IL-8) production were also screened. Of these, Pediococcus pentosaseus (SL4), which inhibited the adhesion of H. pylori to MKN-45 gastric cancer cells, Bifidobacterium longum (BG7), with urease inhibiting activity, and Lactococcus lactis (SL3), and Enterococcus faecalis (SL5), which suppressed H. pylori-induced IL-8 production within MKN-45 and AGS cells, were selected. In mouse model, these LAB stains in combination significantly suppressed IL-8 levels in serum. Gastric pH also recovered to normal values after the administration of these LAB. These stains effectively suppressed H. pylori viability, although not to the extent of antibiotic treatment. When used as probiotics, LAB may help decrease the occurrence of gastritis and reduce the risk of H. pylori infection without, inducing side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aiba Y., Suzuki N., Kabir A.M., Takagi A., and Koga Y. 1998. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol. 93, 2097–2101.

    Article  CAS  PubMed  Google Scholar 

  • Aydin A., Onder G.F., Akarca U.S., Tekin F., Tuncyurek M., and Musoglu A. 2005. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases. Turk. J. Gastroenterol. 16, 203–206.

    PubMed  Google Scholar 

  • Boonyaritichaikij S., Kuwabara K., Nagano J., Kobayashi K., and Koga Y. 2009. Long-term administration of probiotics to asymptomatic pre-school children for either the eradication or the prevention of Helicobacter pylori infection. Helicobacter 14, 202–207.

    Article  PubMed  Google Scholar 

  • Chey W.D., Wong B.C., and Practice Parameters Committee of the American College of, G. 2007. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 102, 1808–1825.

    Article  CAS  PubMed  Google Scholar 

  • Coconnier M.H., Lievin V., Hemery E., and Servin A.L. 1998. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol. 64, 4573–4580.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Corr S.C., Gahan C.G., and Hill C. 2007. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol. Med. Microbiol. 50, 380–388.

    Article  CAS  PubMed  Google Scholar 

  • Cremonini F., Di Caro S., Covino M., Armuzzi A., Gabrielli M., Santarelli L., Nista E.C., Cammarota G., Gasbarrini G., and Gasbarrini A. 2002. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am. J. Gastroenterol. 97, 2744–2749.

    Article  PubMed  Google Scholar 

  • De Keersmaecker S.C., Verhoeven T.L., Desair J., Marchal K., Vanderleyden J., and Nagy I. 2006. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiol. Lett. 259, 89–96.

    Article  PubMed  Google Scholar 

  • Fernandez M.F., Boris S., and Barbes C. 2003. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J. Appl. Microbiol. 94, 449–455.

    Article  CAS  PubMed  Google Scholar 

  • Gotteland M., Brunser O., and Cruchet S. 2006. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment. Pharmacol. Ther. 23, 1077–1086.

    Article  CAS  PubMed  Google Scholar 

  • Hamilton-Miller J.M. 2003. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. J. Antimicrob. Agents 22, 360–366.

    Article  CAS  PubMed  Google Scholar 

  • Hazell S.L., Borody T.J., Gal A., and Lee A. 1987. Campylobacter pyloridis gastritis I: Detection of urease as a marker of bacterial colonization and gastritis. Am. J. Gastroenterol. 82, 292–296.

    CAS  PubMed  Google Scholar 

  • Hsieh P.S., Tsai Y.C., Chen Y.C., Teh S.F., Ou C.M., and King V.A. 2012. Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32. Helicobacter 17, 466–477.

    Article  PubMed  Google Scholar 

  • Ierardi E., Giorgio F., Losurdo G., Di Leo A., and Principi M. 2013. How antibiotic resistances could change treatment: A matter of geography? World J. Gastroenterol. 19, 8168–8180.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Innocenti M., Thoreson A.C., Ferrero R.L., Stromberg E., Bolin I., Eriksson L., Svennerholm A.M., and Quiding-Jarbrink M. 2002. Helicobacter pylori-induced activation of human endothelial cells. Infect. Immun. 70, 4581–4590.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Johnson-Henry K.C., Mitchell D.J., Avitzur Y., Galindo-Mata E., Jones N.L., and Sherman P.M. 2004. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig. Dis. Sci. 49, 1095–1102.

    Article  PubMed  Google Scholar 

  • Johnson-Henry K.C., Nadjafi M., Avitzur Y., Mitchell D.J., Ngan B.Y., Galindo-Mata E., Jones N.L., and Sherman P.M. 2005. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J. Infect. Dis. 191, 2106–2117.

    Article  PubMed  Google Scholar 

  • Joseph I.M. and Kirschner D. 2004. A model for the study of Helicobacter pylori interaction with human gastric acid secretion. J. Theor. Biol. 228, 55–80.

    Article  CAS  PubMed  Google Scholar 

  • Kabir A.M., Aiba Y., Takagi A., Kamiya S., Miwa T., and Koga Y. 1997. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41, 49–55.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kamiji M.M. and de Oliveira R.B. 2005. Non-antibiotic therapies for Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 17, 973–981.

    Article  CAS  PubMed  Google Scholar 

  • Kim M.N., Kim N., Lee S.H., Park Y.S., Hwang J.H., Kim J.W., Jeong S.H., Lee D.H., Kim J.S., Jung H.C., and Song I.S. 2008. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter 13, 261–268.

    Article  CAS  PubMed  Google Scholar 

  • Kuwahara H., Miyamoto Y., Akaike T., Kubota T., Sawa T., Okamoto S., and Maeda H. 2000. Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production. Infect. Immun. 68, 4378–4383.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lee A., O’Rourke J., De Ungria M.C., Robertson B., Daskalopoulos G., and Dixon M.F. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112, 1386–1397.

    Article  CAS  PubMed  Google Scholar 

  • Lind T., Megraud F., Unge P., Bayerdorffer E., O’Morain C., Spiller R., Veldhuyzen Van Zanten S., Bardhan K.D., Hellblom M., Wrangstadh M., and et al. 1999. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 116, 248–253.

    Article  CAS  PubMed  Google Scholar 

  • Lionetti E., Indrio F., Pavone L., Borrelli G., Cavallo L., and Francavilla R. 2010. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter 15, 79–87.

    Article  CAS  PubMed  Google Scholar 

  • Mack D.R., Michail S., Wei S., McDougall L., and Hollingsworth M.A. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276, G941–950.

    Google Scholar 

  • Maeda S., Yoshida H., Matsunaga H., Ogura K., Kawamata O., Shiratori Y., and Omata M. 2000. Detection of clarithromycinresistant Helicobacter pylori strains by a preferential homoduplex formation assay. J. Clin. Microbiol. 38, 210–214.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Maeda S., Yoshida H., Ogura K., Kanai F., Shiratori Y., and Omata M. 1998. Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 43, 317–321.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Malfertheiner P., Megraud F., O’Morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., and Kuipers E.J. 2007. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56, 772–781.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Marshall B.J. 1994. Helicobacter pylori. Am. J. Gastroenterol. 89, S116–128.

    Google Scholar 

  • Matsumoto M., Hara K., and Benno Y. 2007. The influence of the immunostimulation by bacterial cell components derived from altered large intestinal microbiota on probiotic anti-inflammatory benefits. FEMS Immunol. Med. Microbiol. 49, 387–390.

    Article  CAS  PubMed  Google Scholar 

  • Nam H., Ha M., Bae O., and Lee Y. 2002. Effect of Weissella confusa strain PL9001 on the adherence and growth of Helicobacter pylori. Appl. Environ. Microbiol. 68, 4642–4645.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ohana M., Okazaki K., Oshima C., Kawasaki K., Fukui T., Tamaki H., Matsuura M., Asada M., Nishi T., Uchida K., and et al. 2003. Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritis. Gut 52, 1102–1110.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rokka S., Myllykangas S., and Joutsjoki V. 2008. Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL-8 production. Scand. J. Immunol. 68, 280–286.

    Article  CAS  PubMed  Google Scholar 

  • Sachdeva A. and Nagpal J. 2009. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials. Eur. J. Gastroenterol. Hepatol. 21, 45–53.

    Article  PubMed  Google Scholar 

  • Sakamoto I., Igarashi M., Kimura K., Takagi A., Miwa T., and Koga Y. 2001. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother. 47, 709–710.

    Article  CAS  PubMed  Google Scholar 

  • Sartor R.B. 2005. Probiotic therapy of intestinal inflammation and infections. Curr. Opin. Gastroenterol. 21, 44–50.

    PubMed  Google Scholar 

  • Sgouras D., Maragkoudakis P., Petraki K., Martinez-Gonzalez B., Eriotou E., Michopoulos S., Kalantzopoulos G., Tsakalidou E., and Mentis A. 2004. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl. Environ. Microbiol. 70, 518–526.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sgouras D.N., Panayotopoulou E.G., Martinez-Gonzalez B., Petraki K., Michopoulos S., and Mentis A. 2005. Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clin. Diagn. Lab. Immunol. 12, 1378–1386.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sheu B.S., Wu J.J., Lo C.Y., Wu H.W., Chen J.H., Lin Y.S., and Lin M.D. 2002. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 16, 1669–1675.

    Article  PubMed  Google Scholar 

  • Tien M.T., Girardin S.E., Regnault B., Le Bourhis L., Dillies M.A., Coppee J.Y., Bourdet-Sicard R., Sansonetti P.J., and Pedron T. 2006. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 176, 1228–1237.

    Article  CAS  PubMed  Google Scholar 

  • Tsai C.C., Hsih H.Y., Chiu H.H., Lai Y.Y., Liu J.H., Yu B., and Tsen H.Y. 2005. Antagonistic activity against Salmonella infection in vitro and in vivo for two Lactobacillus strains from swine and poultry. Int. J. Food Microbiol. 102, 185–194.

    Article  PubMed  Google Scholar 

  • Ushiyama A., Tanaka K., Aiba Y., Shiba T., Takagi A., Mine T., and Koga Y. 2003. Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection. J. Gastroenterol. Hepatol. 18, 986–991.

    Article  PubMed  Google Scholar 

  • Vitor J.M. and Vale F.F. 2011. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunol. Med. Microbiol. 63, 153–164.

    Article  CAS  PubMed  Google Scholar 

  • Wang F., Meng W., Wang B., and Qiao L. 2014. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 345, 196–202.

    Article  CAS  PubMed  Google Scholar 

  • Yang Y.J., Chuang C.C., Yang H.B., Lu C.C., and Sheu B.S. 2012. Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFkappaB pathways. BMC Microbiol. 12, 38.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zhang L., Su P., Henriksson A., O’Rourke J., and Mitchell H. 2008. Investigation of the immunomodulatory effects of Lactobacillus casei and Bifidobacterium lactis on Helicobacter pylori infection. Helicobacter 13, 183–190.

    Article  CAS  PubMed  Google Scholar 

  • Zou J., Dong J., and Yu X. 2009. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter 14, 97–107.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. R&D Center, Cell Biotech, Co. Ltd., Gimpo, 415-871, Republic of Korea

    Jin-Eung Kim, Min-Soo Kim, Yeo-Sang Yoon, Myung-Jun Chung & Do-Young Yum

Authors
  1. Jin-Eung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Min-Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yeo-Sang Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Myung-Jun Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Do-Young Yum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Do-Young Yum.

Additional information

These authors contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, JE., Kim, MS., Yoon, YS. et al. Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection. J Microbiol. 52, 955–962 (2014). https://doi.org/10.1007/s12275-014-4355-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12275-014-4355-y

Keywords

Search

Navigation